{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T11:12:04Z","timestamp":1792062724647,"version":"4.4.0"},"reference-count":35,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2009,2,1]],"date-time":"2009-02-01T00:00:00Z","timestamp":1233446400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of the American Academy of Child & Adolescent Psychiatry"],"published-print":{"date-parts":[[2009,2]]},"DOI":"10.1097\/chi.0b013e318191769e","type":"journal-article","created":{"date-parts":[[2009,1,15]],"date-time":"2009-01-15T03:19:56Z","timestamp":1231989596000},"page":"155-165","source":"Crossref","is-referenced-by-count":203,"title":["Guanfacine Extended Release in Children and Adolescents With Attention-Deficit\/Hyperactivity Disorder: A Placebo-Controlled Trial"],"prefix":"10.1016","volume":"48","author":[{"given":"Floyd R.","family":"Sallee","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James","family":"Mcgough","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tim","family":"Wigal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica","family":"Donahue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Lyne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph","family":"Biederman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1097\/CHI.0b013e318191769e_bib1","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1542\/peds.105.5.1158","article-title":"Clinical practice guideline: diagnosis and evaluation of the child with attention-deficit\/hyperactivity disorder","volume":"105","author":"American Academy of Pediatrics","year":"2000","journal-title":"Pediatrics"},{"key":"10.1097\/CHI.0b013e318191769e_bib2","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1016\/j.biopsych.2004.08.026","article-title":"The neuropsychopharmacology of attention-deficit\/hyperactivity disorder","volume":"57","author":"Pliszka","year":"2005","journal-title":"Biol Psychiatry"},{"key":"10.1097\/CHI.0b013e318191769e_bib3","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1016\/j.biopsych.2004.08.019","article-title":"Neurobiology of executive functions: catechola-mine influences on prefrontal cortical functions","volume":"57","author":"Arnsten","year":"2005","journal-title":"Biol Psychiatry"},{"key":"10.1097\/CHI.0b013e318191769e_bib4","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1176\/appi.ajp.158.7.1067","article-title":"A placebo-controlled study of guanfacine in the treatment of children with tic disorders and attention deficit hyperactivity disorder","volume":"158","author":"Scahill","year":"2001","journal-title":"Am J Psychiatry"},{"issue":"Suppl","key":"10.1097\/CHI.0b013e318191769e_bib5","first-page":"S117","article-title":"New options in the pharmacological management of attention-deficit\/hyperactivity disorder","volume":"10","author":"Olfson","year":"2004","journal-title":"Am J Manag Care"},{"key":"10.1097\/CHI.0b013e318191769e_bib6","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1089\/cap.1990.1.87","article-title":"Clonidine in child and adolescent psychiatry","volume":"1","author":"Hunt","year":"1990","journal-title":"J Child Adolesc Psychopharmacol"},{"key":"10.1097\/CHI.0b013e318191769e_bib7","doi-asserted-by":"crossref","first-page":"4287","DOI":"10.1523\/JNEUROSCI.08-11-04287.1988","article-title":"The alpha-2 adrenergic agonist guanfacine improves memory in aged monkeys without sedative or hypotensive side effects: evidence for alpha-2 receptor subtypes","volume":"8","author":"Arnsten","year":"1988","journal-title":"J Neurosci"},{"key":"10.1097\/CHI.0b013e318191769e_bib8","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/0014-2999(91)90299-6","article-title":"Delineation of rat kidney \u03b12A- and \u03b12B-adrenoceptors with [3H]RX821002 radioligand binding: computer modelling reveals that guanfacine is an \u03b12A-selective compound","volume":"202","author":"Uhl\u00e9n","year":"1991","journal-title":"Eur J Pharmacol"},{"key":"10.1097\/CHI.0b013e318191769e_bib9","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/j.cell.2007.03.015","article-title":"\u03b12A-adrenoceptors strengthen working memory networks by inhibiting cAMP-HCN channel signaling in prefrontal cortex","volume":"129","author":"Wang","year":"2007","journal-title":"Cell"},{"key":"10.1097\/CHI.0b013e318191769e_bib10","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1016\/S0893-133X(99)00070-6","article-title":"Alpha-2 adrenergic modulation of prefrontal cortical neuronal activity related to spatial working memory in monkeys","volume":"21","author":"Li","year":"1999","journal-title":"Neuropsychopharmacology"},{"issue":"Suppl 1","key":"10.1097\/CHI.0b013e318191769e_bib11","doi-asserted-by":"crossref","first-page":"i6","DOI":"10.1093\/cercor\/bhm033","article-title":"Catecholamine and second messenger influences on prefrontal cortical networks of \u201crepresentational knowledge\u201d: a rational bridge between genetics and the symptoms of mental illness","volume":"17","author":"Arnsten","year":"2007","journal-title":"Cereb Cortex"},{"key":"10.1097\/CHI.0b013e318191769e_bib12","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1097\/00004583-199509000-00010","article-title":"Guanfacine treatment of comorbid attention-deficit hyperactivity disorder and Tourette's syndrome: preliminary clinical experience","volume":"34","author":"Chappell","year":"1995","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"10.1097\/CHI.0b013e318191769e_bib13","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1016\/j.biopsych.2005.09.011","article-title":"A randomized, placebo-controlled trial of OROS methylphenidate in adults with attention-deficit\/hyperactivity disorder","volume":"59","author":"Biederman","year":"2006","journal-title":"Biol Psychiatry"},{"key":"10.1097\/CHI.0b013e318191769e_bib14","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1097\/00004583-199501000-00013","article-title":"An open trial of guanfacine in the treatment of attention-deficit hyperactivity disorder","volume":"34","author":"Hunt","year":"1995","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"10.1097\/CHI.0b013e318191769e_bib15","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1097\/00004714-200104000-00015","article-title":"Comparing guanfacine and dextroamphetamine for the treatment of adult attention-deficit\/hyperactivity disorder","volume":"21","author":"Taylor","year":"2001","journal-title":"J Clin Psychopharmacol"},{"key":"10.1097\/CHI.0b013e318191769e_bib16","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1089\/cap.2006.0098","article-title":"Alpha-2 adrenergic receptor agonists for the treatment of attention-deficit\/hyperactivity disorder: emerging concepts from new data","volume":"17","author":"Arnsten","year":"2007","journal-title":"J Child Adolesc Psychopharmacol"},{"key":"10.1097\/CHI.0b013e318191769e_bib17","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1002\/cpt1979253283","article-title":"Guanfacine kinetics in patients with hypertension","volume":"25","author":"Weiss","year":"1979","journal-title":"Clin Pharmacol Ther"},{"key":"10.1097\/CHI.0b013e318191769e_bib18","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1002\/j.1552-4604.1987.tb02993.x","article-title":"The bioavailability and pharmacokinetics of guanfacine after oral and intravenous administration to healthy volunteers","volume":"27","author":"Carchman","year":"1987","journal-title":"J Clin Pharmacol"},{"key":"10.1097\/CHI.0b013e318191769e_bib19","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1016\/j.clinthera.2007.04.016","article-title":"A phase I, randomized, open-label, crossover study of the single-dose pharmacokinetic properties of guanfacine extended-release 1-, 2-, and 4-mg tablets in healthy adults","volume":"29","author":"Swearingen","year":"2007","journal-title":"Clin Ther"},{"key":"10.1097\/CHI.0b013e318191769e_bib20","doi-asserted-by":"crossref","first-page":"e73","DOI":"10.1542\/peds.2006-3695","article-title":"A randomized, double-blind, placebo-controlled study of guanfacine extended release in children and adolescents with attention-deficit\/hyperactivity disorder","volume":"121","author":"Biederman","year":"2008","journal-title":"Pediatrics"},{"key":"10.1097\/CHI.0b013e318191769e_bib21","series-title":"ADHD Rating Scale\u2013IV: Checklists, Norms, and Clinical Interpretation","author":"DuPaul","year":"1998"},{"key":"10.1097\/CHI.0b013e318191769e_bib22","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1097\/00004583-199707000-00021","article-title":"Schedule for Affective Disorders and Schizophrenia for School-Age Children-Present and Lifetime Version (K-SADS-PL): initial reliability and validity data","volume":"36","author":"Kaufman","year":"1997","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"10.1097\/CHI.0b013e318191769e_bib23","author":"US Department of Health and Human Services"},{"key":"10.1097\/CHI.0b013e318191769e_bib24","first-page":"455","article-title":"The pediatric daytime sleepiness scale (PDSS): sleep habits and school outcomes in middle-school children","volume":"26","author":"Drake","year":"2003","journal-title":"Sleep"},{"key":"10.1097\/CHI.0b013e318191769e_bib25","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1542\/peds.114.1.e1","article-title":"Once-daily atomoxetine treatment for children with attention-deficit\/hyperactivity disorder, including an assessment of evening and morning behavior: a double-blind, placebo-controlled trial","volume":"114","author":"Kelsey","year":"2004","journal-title":"Pediatrics"},{"key":"10.1097\/CHI.0b013e318191769e_bib26","doi-asserted-by":"crossref","first-page":"1896","DOI":"10.1176\/appi.ajp.159.11.1896","article-title":"Once-daily atomoxetine treatment for children and adolescents with attention deficit hyperactivity disorder: a randomized, placebo-controlled study","volume":"159","author":"Michelson","year":"2002","journal-title":"Am J Psychiatry"},{"key":"10.1097\/CHI.0b013e318191769e_bib27","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.4088\/JCP.v63n1209","article-title":"Results from 2 proof-of-concept, placebo-controlled studies of atomoxetine in children with attention-deficit\/hyperactivity disorder","volume":"63","author":"Spencer","year":"2002","journal-title":"J Clin Psychiatry"},{"key":"10.1097\/CHI.0b013e318191769e_bib28","first-page":"4","article-title":"Comparing the efficacy of medications for ADHD using meta-analysis","volume":"8","author":"Faraone","year":"2006","journal-title":"Med Gen Med"},{"key":"10.1097\/CHI.0b013e318191769e_bib29","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1097\/01.jcp.0000108984.11879.95","article-title":"Meta-analysis of the efficacy of methylphenidate for treating adult attention-deficit\/hyperactivity disorder","volume":"24","author":"Faraone","year":"2004","journal-title":"J Clin Psychopharmacol"},{"key":"10.1097\/CHI.0b013e318191769e_bib30","doi-asserted-by":"crossref","first-page":"833","DOI":"10.2165\/00148581-200305120-00006","article-title":"Efficacy and safety of Ritalin LA, a new, once daily, extended-release dosage form of methylphenidate, in children with attention deficit hyperactivity disorder","volume":"5","author":"Biederman","year":"2003","journal-title":"Paediatr Drugs"},{"key":"10.1097\/CHI.0b013e318191769e_bib31","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.1097\/00004583-199610000-00018","article-title":"Bupropion hydrochloride in attention deficit disorder with hyperactivity","volume":"35","author":"Conners","year":"1996","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"10.1097\/CHI.0b013e318191769e_bib32","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1097\/01.chi.0000205709.63571.c9","article-title":"A randomized, double-blind, placebo-controlled study of modafinil film-coated tablets in children and adolescents with attention-deficit\/hyperactivity disorder","volume":"45","author":"Greenhill","year":"2006","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"10.1097\/CHI.0b013e318191769e_bib33","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.1097\/00004583-199912000-00017","article-title":"A meta-analysis of clonidine for symptoms of attention-deficit hyperactivity disorder","volume":"38","author":"Connor","year":"1999","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"10.1097\/CHI.0b013e318191769e_bib34","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1177\/1087054705284089","article-title":"A randomized, double-blind, placebo-controlled, laboratory classroom assessment of methylphenidate transdermal system in children with ADHD","volume":"9","author":"McGough","year":"2006","journal-title":"J Atten Disord"},{"key":"10.1097\/CHI.0b013e318191769e_bib35","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1016\/S0149-2918(07)80083-X","article-title":"Efficacy and tolerability of lisdexamfetamine dimesylate (NRP-104) in children with attention-deficit\/hyperactivity disorder: a phase III, multicenter, randomized, double-blind, forced-dose, parallel-group study","volume":"29","author":"Biederman","year":"2007","journal-title":"Clin Ther"}],"container-title":["Journal of the American Academy of Child & Adolescent Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0890856709600095?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0890856709600095?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,5,17]],"date-time":"2019-05-17T04:54:59Z","timestamp":1558068899000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0890856709600095"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,2]]},"references-count":35,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2009,2]]}},"alternative-id":["S0890856709600095"],"URL":"https:\/\/doi.org\/10.1097\/chi.0b013e318191769e","relation":{},"ISSN":["0890-8567"],"issn-type":[{"value":"0890-8567","type":"print"}],"subject":[],"published":{"date-parts":[[2009,2]]}}}